UNIGE document Scientific Article - Review
previous document  unige:125944  next document
add to browser collection
Title

Fecal microbiota transplantation: a promising strategy in preventing the progression of non-alcoholic steatohepatitis and improving the anti-cancer immune response

Authors
Published in Expert Opinion on Biological Therapy. 2018, vol. 18, no. 10, p. 1061-1071
Abstract Non-alcoholic fatty liver disease (NAFLD) has the potential to progress to hepatocellular carcinoma (HCC). However, limited therapies are currently available for the treatment of advanced HCC, and one must strive to search for novel strategies. Areas covered: We provide insight on current knowledge related to gut microbiota and NAFLD, summarize the sequence linking obesity to HCC and highlight gut dysbiosis in obesity and its consequences on the liver. We detail the impact of the gut microbiota on immune checkpoint inhibitors, and speculate on the role of fecal microbiota transplantation (FMT) in NAFLD and in improving anti-neoplastic immune response. Expert Opinion: Manipulation of the gut microbiota seems promising in the secondary prevention of NAFLD/NASH and/or in potentiating anti-cancer immune response, notably by a global 'resetting' using FMT. However, the composition of a 'harmful' gut microbiome in HCC still needs to be characterized, and the impact of FMT on HCC growth needs to be assessed.
Keywords CancerCheckpoint inhibitorsFecal microbiota transplantationGut microbiotaHepatocellular carcinomaImmunotherapyMetabolic syndromeNon-alcoholic fatty liver diseaseNon-alcoholic steatohepatitisObesity
Identifiers
PMID: 30173562
Full text
Article (Published version) (2.2 MB) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research groups Transplantation et hépatologie (905)
Analyse génomique et fonctionnelle du staphylocoque doré (604)
Project FNS: PP00P3_165837
Citation
(ISO format)
DELAUNE, Vaihere et al. Fecal microbiota transplantation: a promising strategy in preventing the progression of non-alcoholic steatohepatitis and improving the anti-cancer immune response. In: Expert Opinion on Biological Therapy, 2018, vol. 18, n° 10, p. 1061-1071. doi: 10.1080/14712598.2018.1518424 https://archive-ouverte.unige.ch/unige:125944

168 hits

2 downloads

Update

Deposited on : 2019-11-12

Export document
Format :
Citation style :